My HPRA: Register

GAVISCON ADVANCE

500/100 Milligram Tablets Chewable

Reckitt Benckiser Ireland LtdPA0979/011/008

Main Information

Trade NameGAVISCON ADVANCE
Active SubstancesSODIUM ALGINATE
POTASSIUM BICARBONATE
Strength500/100 Milligram
Dosage FormTablets Chewable
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/011/008

Group Information

ATC CodeA02BX13 Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

Status

Authorised/WithdrawnAuthorised
Licence Issued10/02/2006
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings